Lamotrigine

Lamotrigine (CAS 84057-84-1), marketed under the brand name Lamictal®, is an established active pharmaceutical ingredient used in the treatment of epilepsy and bipolar disorder. As a finished API and pharmaceutical intermediate, it serves as the basis for a broad range of prescription solid dosage formulations manufactured globally by pharmaceutical companies.

This compound is primarily sourced by generic drug manufacturers producing tablets, chewable dispersible tablets, and extended-release oral solid forms for various neurological indications. Contract development and manufacturing organizations procure it as a key API input for formulation development projects targeting regulated markets including the US, EU, and emerging economies.

Pharmaceutical importers and distributors handling controlled substance supply chains source it to fulfill hospital, pharmacy, and tender requirements for healthcare systems worldwide. It also functions as a reference standard or synthetic building block for research institutions and API developers working on triazine-based heterocyclic compounds and related chemistry.

The product is supplied as a white to off-white crystalline powder. It is available in USP, BP, and Ph. Eur. pharmacopoeial grades to meet specification requirements. Bulk quantities are typically offered in kilogram and multi-kilogram packaging with full regulatory documentation including CoA, DMF references, and ICH-compliant impurity profiles.